Synthetic Peptide
TMEM106B Synthetic Peptide, PEP-1396, from Invitrogen.
Transmembrane protein 106B (TMEM106B) is a single-pass transmembrane protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual role of TMEM106B, and that of the closely related protein TMEM106A are still undetermined.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-175646 |
| Réf. fabricant | 15215309 |
| Gene ID (Entrez) | 54664 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | Q9NUM4 |
| Nom usuel | Human TMEM106B |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | TMEM106B |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |
